肿瘤相关高血压的血压管理的研究进展  

Blood Pressure Management of Tumor-Associated Hypertension

作　　者：蒋弼瀛 黄佳宇 陈文佳[1] JIANG Biying;HUANG Jiayu;CHEN Wenjia(Department of Cardiology,The First Affiliated Hospital of Harbin Medical University,Harbin 150001,Heilongjiang,China)

机构地区：[1]哈尔滨医科大学附属第一医院心内科,黑龙江哈尔滨150001

出　　处：《心血管病学进展》2024年第1期52-56,共5页Advances in Cardiovascular Diseases

基　　金：国家自然科学基金(81800419);黑龙江省自然科学基金青年科学基金(QC2017104);哈尔滨医科大学附属第一医院科研创新基金(2019M08)。

摘　　要：近年来众多研究证实长期使用抗高血压药治疗及高血压本身会导致肿瘤发病风险增加,同时在应用抗肿瘤药过程中也会导致高血压的发生。然而,目前仍缺乏有关肿瘤患者合并高血压的最佳血压管理方法。现强调高血压与肿瘤之间的关系,并讨论接受抗肿瘤药治疗的肿瘤患者的血压控制目标以及评估和管理策略。肿瘤患者的血压达标对于降低抗肿瘤治疗引起的心脏毒性和心血管疾病的风险至关重要。In recent years,many studies have confirmed that long-term use of anti-hypertensive drugs and hypertension itself will lead to an increased risk of tumor,at the same time,it will also lead to the occurrence of hypertension during the use of anti-tumor drugs.However,there is still a lack of optimal blood pressure management methods for cancer patients with hypertension.This review highlights the relationship between hypertension and tumor and discusses the objectives of blood pressure control,evaluation and management strategies for tumor patients treated with anti-tumor drugs.It is of utmost importance to maintain optimal blood pressure control in the tumor patients to reduce the risk of cardiotoxicity and cardiovascular disease caused by anti-tumor therapy.

关 键 词：高血压 肿瘤 抗肿瘤治疗 血压管理 

分 类 号：R544.1[医药卫生—心血管疾病] R730.5[医药卫生—内科学]